Neurology
RSSArticles
-
Recent Advances in Sleep Medicine
This article reviews recently published research on sleep medicine. -
Primary Headaches: Look, Listen, and Diagnose Rather Than Image
SYNOPSIS: The diagnosis of primary headache disorders by a computerized and clinical paradigm can predict a baseline prevalence of intracranial abnormalities on brain imaging. Some historical “red flags” in children with headaches, including morning headaches and occipital pain, are not associated with increased intracranial abnormalities.
-
Cerebellar Atrophy May Contribute to Cognitive Impairment in FTD
In this cross-sectional study, researchers identified distinct patterns of cerebellar atrophy and its association with cognitive dysfunction in the frontotemporal dementia syndromes.
-
Ibudilast Shows Promise for the Treatment of Progressive MS
A Phase II trial of ibudilast in progressive multiple sclerosis demonstrated a decreased rate of brain atrophy when compared to placebo.
-
Steroid Treatment Regimens for Chronic Inflammatory Demyelinating Polyneuropathy
In the United States, first-line treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) is intravenous immunoglobulin (IVIG). Authors of this retrospective survey from Europe found that corticosteroid treatment had similar efficacy as IVIG and should be considered as first-line therapy for CIDP.
-
Elagolix (Orilissa)
Elagolix is indicated for the management of moderate to severe pain associated with endometriosis.
-
Treatment of Chronic Subdural Hematoma With Atorvastatin
The results of a recent study suggest that atorvastatin may be a safe and effective nonsurgical alternative for patients with chronic subdural hematoma.
-
Inappropriate Outpatient Antibiotic Prescribing: The Need to Target Urgent Care Centers
Urgent care centers, which are part of a growth industry, are responsible for a large proportion of antibiotic prescriptions, including inappropriate prescriptions for acute respiratory diagnoses.
-
Latent Tuberculosis Treatment With 4 Months of Rifampin Compared to 9 Months of Isoniazid
In an open-label trial, adults with latent tuberculosis infection were randomized to either four months of treatment with rifampin or nine months of treatment with isoniazid. The four-month rifampin regimen was non-inferior to nine months of isoniazid for prevention of active tuberculosis.
-
Vitamin C for Postoperative Atrial Fibrillation Risk
Vitamin C supplementation decreases the risk of developing postoperative atrial fibrillation.